Atea Pharmaceuticals logo

Atea Pharmaceuticals share price today

(AVIR)

Atea Pharmaceuticals share price is $3.35 & ₹286.93 as on 1 Jan 2025, 2.30 'hrs' IST

$3.35

0.02

(0.6%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Atea Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Atea Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Atea Pharmaceuticals. Get details on the Indian mutual funds that are investing in Atea Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Atea Pharmaceuticals's financials.

Atea Pharmaceuticals share price movements

  • Today's Low: $3.33
    Today's High: $3.40

    Day's Volatility :2.06%

  • 52 Weeks Low: $2.75
    52 Weeks High: $4.60

    52 Weeks Volatility :40.22%

Atea Pharmaceuticals Returns

PeriodAtea Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
0.6%
-10.0%
0.0%
6 Months
3.08%
-4.7%
0.0%
1 Year
6.01%
-0.9%
0.0%
3 Years
-63.55%
-2.4%
-21.2%

Atea Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$3.33
Open
$3.33
Today's High
$3.4
Today's Low
$3.33
Market Capitalization
$283.0M
Today's Volume
$325.3K
52 Week High
$4.6
52 Week Low
$2.75
Revenue TTM
$192.2M
EBITDA
$-124.9M
Earnings Per Share (EPS)
$-2.07
Profit Margin
0.0%
Quarterly Earnings Growth YOY
2.64%
Return On Equity TTM
-33.46%

How to invest in Atea Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Atea Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atea Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atea Pharmaceuticals or AVIR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atea Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atea Pharmaceuticals shares which would translate to 0.256 fractional shares of Atea Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atea Pharmaceuticals, in just a few clicks!

Returns in Atea Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atea Pharmaceuticals investment value today

Current value as on today

₹1,08,879

Returns

₹8,879

(+8.88%)

Returns from Atea Pharmaceuticals Stock

₹6,013 (+6.01%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Atea Pharmaceuticals

0%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Atea Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Jan 2, 2025. 0% more investors are searching Atea Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Atea Pharmaceuticals

  • BlackRock Inc

    10.80%

  • BML Capital Management LLC

    7.87%

  • FMR Inc

    7.84%

  • EcoR1 Capital, LLC

    6.44%

  • Vanguard Group Inc

    5.74%

  • TANG CAPITAL MANAGEMENT LLC

    5.45%

Analyst Recommendation on Atea Pharmaceuticals

Sell

    11%Buy

    33%Hold

    55%Sell

Based on 9 Wall street analysts offering stock ratings for Atea Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
3
3
3
Sell
5
5
5

Analyst Forecast on Atea Pharmaceuticals

What analysts predicted

Upside of 120.9%

Current:

$3.35

Target:

$7.40

Insights on Atea Pharmaceuticals

  • Price Movement

    In the last 7 days, AVIR stock has moved up by 1.8%
  • AVIR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 16.3%
  • AVIR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 101.3%
  • Price to Sales

    ForAVIR every $1 of sales, investors are willing to pay $1.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Atea Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Atea Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Atea Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atea Pharmaceuticals Inc
-3.74%
3.08%
6.01%
-63.55%
-88.96%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-22.37%
13.59%
91.62%
Biontech Se
-1.42%
42.28%
3.53%
-50.85%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
23.43%
35.31%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-1.95%
80.96%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atea Pharmaceuticals Inc
11.84
NA
NA
-1.81
-0.33
-0.14
NA
5.43
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atea Pharmaceuticals Inc
Sell
$283.0M
-88.96%
11.84
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Atea Pharmaceuticals

atea pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for severe viral diseases. the company's lead product candidate is at-527, a novel antiviral agent for the treatment of patients infected with severe acute respiratory syndrome coronavirus 2 and is under phase 3 clinical trial. it also develops at-787 which is under phase 2 clinical for the treatment of hepatitis c virus; at-752 which is under phase 2 clinical trial for the treatment of dengue; and at-889, at-934, and other product candidates for the treatment of respiratory syncytial virus are under phase 2 clinical trials. the company was incorporated in 2012 and is based in boston, massachusetts.
Organization
Atea Pharmaceuticals
Employees
75
CEO
Dr. Jean-Pierre Sommadossi Ph.D.
Industry
Health Technology

Management People of Atea Pharmaceuticals

NameTitle
Dr. Jean-Pierre Sommadossi Ph.D.
Founder, Chairman, CEO & President
Ms. Andrea J. Corcoran J.D.
CFO, Executive VP of Legal & Secretary
Mr. Wayne Foster CPA
Executive VP of Finance & Chief Accounting Officer
Dr. Janet M. J. Hammond M.D., Ph.D.
Chief Development Officer
Dr. Maria Arantxa Horga M.D.
Chief Medical Officer
Ms. Jonae R. Barnes
Senior Vice President of Investor Relations & Corporate Communications
Mr. Ariyapadi N. Krishnaraj
Vice President of Marketing
Mr. Adel Moussa Ph.D.
Executive Vice President of Chemistry
Mr. Xiao-Jian Zhou Ph.D.
Executive Vice President of Early Stage Development
Mr. John F. Vavricka
Chief Commercial Officer

Important FAQs about investing in Atea Pharmaceuticals from India :

What is Atea Pharmaceuticals share price today?

Atea Pharmaceuticals share price today stands at $3.35, Open: $3.33 ; Previous Close: $3.33 ; High: $3.40 ; Low: $3.33 ; 52 Week High: $4.60 ; 52 Week Low: $2.75. The stock opens at $3.33, after a previous close of $3.33. The stock reached a daily high of $3.40 and a low of $3.33, with a 52-week high of $4.60 and a 52-week low of $2.75.

Can Indians buy Atea Pharmaceuticals shares?

Yes, Indians can invest in the Atea Pharmaceuticals (AVIR) from India.

With INDmoney, you can buy Atea Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Atea Pharmaceuticals at zero transaction cost.

How can I buy Atea Pharmaceuticals shares from India?

It is very easy to buy Atea Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atea Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Atea Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Atea Pharmaceuticals stocks?

To start investing in Atea Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Atea Pharmaceuticals

Today’s highest price of Atea Pharmaceuticals (AVIR) is $3.40.

Today’s lowest price of Atea Pharmaceuticals (AVIR) is $3.33.

What is today's market capitalisation of Atea Pharmaceuticals

Today's market capitalisation of Atea Pharmaceuticals AVIR is 283.0M

What is the 52 Week High and Low Range of Atea Pharmaceuticals

  • 52 Week High

    $4.60

  • 52 Week Low

    $2.75

What are the historical returns of Atea Pharmaceuticals?

  • 1 Month Returns

    -3.74%

  • 3 Months Returns

    3.08%

  • 1 Year Returns

    6.01%

  • 5 Years Returns

    -88.96%

Who is the Chief Executive Officer (CEO) of Atea Pharmaceuticals

Dr. Jean-Pierre Sommadossi Ph.D. is the current Chief Executive Officer (CEO) of Atea Pharmaceuticals.